Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors.

BACKGROUND This study investigated the prognostic significance of complete blood count data in castration-resistant prostate cancer patients treated using androgen receptor pathway inhibitors (ARPIs). PATIENTS AND METHODS Patients treated with an ARPI, abiraterone or enzalutamide, as first-line therapy for castration-resistant prostate cancer from 2014 to 2018 were included. The association between complete blood count data and prognoses including progression-free survival and overall survival (OS) was investigated. RESULTS High white blood cell counts (

Keywords:

• Confidence interval
• Prostate cancer
• Gastroenterology
• Enzalutamide
• Medicine
• Red blood cell distribution width
• Internal medicine
• Hazard ratio
• Complete blood count
• White blood cell
• Univariate analysis

• Correction
• Source
• Cite
• Save
• Machine Reading By IdeaReader